WO2001005371A8 - Procede de modification de proprietes physico-chimiques et/ou biologiques d'une substance - Google Patents

Procede de modification de proprietes physico-chimiques et/ou biologiques d'une substance

Info

Publication number
WO2001005371A8
WO2001005371A8 PCT/RU2000/000291 RU0000291W WO0105371A8 WO 2001005371 A8 WO2001005371 A8 WO 2001005371A8 RU 0000291 W RU0000291 W RU 0000291W WO 0105371 A8 WO0105371 A8 WO 0105371A8
Authority
WO
WIPO (PCT)
Prior art keywords
chemical
biological properties
physical
modifying physical
potentiated form
Prior art date
Application number
PCT/RU2000/000291
Other languages
English (en)
French (fr)
Other versions
WO2001005371A1 (fr
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Priority to EA200101260A priority Critical patent/EA200101260A1/ru
Priority to UA2001129264A priority patent/UA74148C2/ru
Priority to AU61909/00A priority patent/AU6190900A/en
Publication of WO2001005371A1 publication Critical patent/WO2001005371A1/ru
Publication of WO2001005371A8 publication Critical patent/WO2001005371A8/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/RU2000/000291 1999-07-16 2000-07-13 Procede de modification de proprietes physico-chimiques et/ou biologiques d'une substance WO2001005371A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EA200101260A EA200101260A1 (ru) 1999-07-16 2000-07-13 Способ изменения физико-химических и/или биологических свойств вещества
UA2001129264A UA74148C2 (ru) 1999-07-16 2000-07-13 Способ изменения физико-химических или физико-химических и биологических свойств вещества
AU61909/00A AU6190900A (en) 1999-07-16 2000-07-13 Method for modifying physical and chemical and/or biological properties of a material

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU99115303 1999-07-16
RU99115303/14A RU2161955C1 (ru) 1999-07-16 1999-07-16 Способ изменения физико-химических или физико-химических и биологических свойств вещества

Publications (2)

Publication Number Publication Date
WO2001005371A1 WO2001005371A1 (fr) 2001-01-25
WO2001005371A8 true WO2001005371A8 (fr) 2001-06-21

Family

ID=20222657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2000/000291 WO2001005371A1 (fr) 1999-07-16 2000-07-13 Procede de modification de proprietes physico-chimiques et/ou biologiques d'une substance

Country Status (5)

Country Link
AU (1) AU6190900A (ru)
EA (1) EA200101260A1 (ru)
RU (1) RU2161955C1 (ru)
UA (1) UA74148C2 (ru)
WO (1) WO2001005371A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (ru) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатическое лекарственное средство и способ лечения заболеваний предстательной железы
UA76639C2 (ru) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатическое лекарственное средство и способ лечения эректильных дисфункций
RU2309732C1 (ru) 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EA200802440A1 (ru) 2006-06-06 2009-06-30 Олег Ильич ЭПШТЕЙН Лекарственное средство для лечения ожирения, сахарного диабета и заболеваний с нарушением толерантности к глюкозе
RU2455650C2 (ru) * 2010-06-18 2012-07-10 Карен Маисович Саканян Способ определения фармакологической активности гомеопатического лекарственного средства
FR2962651A1 (fr) 2010-07-15 2012-01-20 Oleg Iliich Epshtein Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections fonctionnelles du tractus gastro-intestinal
US8987206B2 (en) 2010-07-21 2015-03-24 Oleg Iliich Epshtein Method of treating attention deficit hyperactivity disorder
RU2643934C2 (ru) * 2013-02-19 2018-02-06 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2643936C2 (ru) * 2013-02-19 2018-02-06 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624013B2 (fr) * 1987-10-08 1991-07-12 Medibrevex Application comme medicaments utiles pour le traitement allopathique des maladies allergiques de formes galeniques d'oeufs de caille
RU2084217C1 (ru) * 1996-02-12 1997-07-20 Эпштейн Олег Ильич Лекарственное средство
RU2114608C1 (ru) * 1996-06-25 1998-07-10 Акционерное общество закрытого типа Международный концерн "Эдас" Способ приготовления гомеопатических мягких лекарственных форм

Also Published As

Publication number Publication date
UA74148C2 (ru) 2005-11-15
AU6190900A (en) 2001-02-05
EA200101260A1 (ru) 2002-12-26
WO2001005371A1 (fr) 2001-01-25
RU2161955C1 (ru) 2001-01-20

Similar Documents

Publication Publication Date Title
WO2001005371A8 (fr) Procede de modification de proprietes physico-chimiques et/ou biologiques d'une substance
AP2003002850A0 (en) Method for separating hemicelluloses from a biomass containing hemicelluloses and biomass and hemicelluloses obtained by said method.
EP1395419A4 (en) PRESERVATION OF BIOLOGICAL MATERIALS BY FIBER FORMING TECHNIQUES
WO2001068637A3 (en) Method for the preparation of tetrahydrobenzothiepines
EP2502935A3 (en) Improved antibodies having altered effector function and methods for making the same
WO2000006694A3 (en) Compound and method for the prevention and/or the treatment of allergy
WO2001047959A3 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
IL161244A0 (en) Chemical process for the production of 1,3-diglyceride oils
WO2002046455A3 (en) Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
WO2002030870A3 (de) Substituierte c-cyclohexylmethylamin-derivate
ZA976967B (en) Device and process for separating magnetic materials from pharmaceutical preparations, their starting or intermediate products, as well as agents that are produced with the of said device.
AU1802100A (en) Floating pesticide compositions for paddy fields, method for the utilization thereof and process for producing the same
EP1946767A3 (en) Autologous T-cell vaccines against multiple sclerosis
AU5999199A (en) Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
HUP0303444A3 (en) Improved process for producing emulsified salad dressings
EP2182065A3 (en) Staphylococcus epidermidis antigens
WO2000071553A8 (en) Novel aluminosiloxane compound and process for preparing the same
WO2004007672A3 (en) Methods and materials relating to novel polypeptides and polynucleotides
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
ID27205A (id) Komposisi-komposisi farmasi, fenilamidin tersubstitusi yang mengandung senyawa-senyawa ini dan proses pembuatannya.
WO2001059476A3 (en) Sample preparation method
WO2003048326A3 (en) Methods and materials relating to novel polypeptides and polynucleotides
WO2002086099A3 (de) Exopolysaccharidproduktion
WO2004058998A8 (de) Verfahren zur erstellung einer sammlung von biologischem probenmaterial und probensammlung

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WRT Later publication of a revised version of an international search report translation
WWE Wipo information: entry into national phase

Ref document number: 200101260

Country of ref document: EA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP